Hämmerle L - Search Results

1

In Vitro Investigation of Thiolated Chitosan Derivatives as Mucoadhesive Coating Materials for Solid Lipid Nanoparticles.

Wibel R, Braun DE, Hämmerle L, Jörgensen AM, Knoll P, Salvenmoser W, Steinbring C, Bernkop-Schnürch A. Wibel R, et al. Among authors: hammerle l. Biomacromolecules. 2021 Sep 13;22(9):3980-3991. doi: 10.1021/acs.biomac.1c00776. Epub 2021 Aug 30. Biomacromolecules. 2021. PMID: 34459197 Free PMC article.

2

Structure, polymorphism and luminescence of cyanate iodides MI(OCN) (M = Ba, Eu, and Sr).

Siai A , Hämmerle L , Ströbele M , Enseling D , Jüstel T , Meyer HJ . Siai A , et al. Among authors: hammerle l. Dalton Trans. 2020 Oct 28;49(40):14133-14139. doi: 10.1039/d0dt02126a. Epub 2020 Oct 6. Dalton Trans. 2020. PMID: 33020776

3

Ubiquitin ligase substrate identification through quantitative proteomics at both the protein and peptide levels.

Lee KA, Hammerle LP, Andrews PS, Stokes MP, Mustelin T, Silva JC, Black RA, Doedens JR. Lee KA, et al. Among authors: hammerle lp. J Biol Chem. 2011 Dec 2;286(48):41530-41538. doi: 10.1074/jbc.M111.248856. Epub 2011 Oct 10. J Biol Chem. 2011. PMID: 21987572 Free PMC article.

4

Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes.

Maldonado M, Hampe CS, Gaur LK, D'Amico S, Iyer D, Hammerle LP, Bolgiano D, Rodriguez L, Rajan A, Lernmark A, Balasubramanyam A. Maldonado M, et al. Among authors: hammerle lp. J Clin Endocrinol Metab. 2003 Nov;88(11):5090-8. doi: 10.1210/jc.2003-030180. J Clin Endocrinol Metab. 2003. PMID: 14602731

5

Expression of the vesicular inhibitory amino acid transporter in pancreatic islet cells: distribution of the transporter within rat islets.

Chessler SD, Simonson WT, Sweet IR, Hammerle LP. Chessler SD, et al. Among authors: hammerle lp. Diabetes. 2002 Jun;51(6):1763-71. doi: 10.2337/diabetes.51.6.1763. Diabetes. 2002. PMID: 12031963

6

Preservation of enzyme activity and antigenicity after mutagenesis of the membrane anchoring domain of GAD65.

Plesner A, Hampe CS, Daniels TL, Hammerle LP, Lernmark A. Plesner A, et al. Among authors: hammerle lp. Autoimmunity. 2001;34(4):221-30. doi: 10.3109/08916930109014691. Autoimmunity. 2001. PMID: 11905848

7

Stable GAD65 autoantibody epitope patterns in type 1 diabetes children five years after onset.

Hampe CS, Hammerle LP, Bekris L, Ortqvist E, Persson B, Lernmark A. Hampe CS, et al. Among authors: hammerle lp. J Autoimmun. 2002 Feb;18(1):49-53. doi: 10.1006/jaut.2001.0564. J Autoimmun. 2002. PMID: 11869046

8

Site-directed mutagenesis of K396R of the 65 kDa glutamic acid decarboxylase active site obliterates enzyme activity but not antibody binding.

Hampe CS, Hammerle LP, Falorni A, Robertson J, Lernmark A. Hampe CS, et al. Among authors: hammerle lp. FEBS Lett. 2001 Jan 19;488(3):185-9. doi: 10.1016/s0014-5793(00)02429-7. FEBS Lett. 2001. PMID: 11163769 Free article.

9

A novel monoclonal antibody specific for the N-terminal end of GAD65.

Hampe CS, Lundgren P, Daniels TL, Hammerle LP, Marcovina SM, Lernmark A. Hampe CS, et al. Among authors: hammerle lp. J Neuroimmunol. 2001 Feb 1;113(1):63-71. doi: 10.1016/s0165-5728(00)00423-9. J Neuroimmunol. 2001. PMID: 11137577

10

Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes.

Hampe CS, Hammerle LP, Bekris L, Ortqvist E, Kockum I, Rolandsson O, Landin-Olsson M, Törn C, Persson B, Lernmark A. Hampe CS, et al. Among authors: hammerle lp. J Clin Endocrinol Metab. 2000 Dec;85(12):4671-9. doi: 10.1210/jcem.85.12.7070. J Clin Endocrinol Metab. 2000. PMID: 11134126 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page